Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model

Journal of Pharmacological and Toxicological Methods
Daniela S HauserGuido Hanauer


Assessment of cardiovascular functions in vivo is part of the core battery of guideline ICH S7A and is thereby required by regulatory authorities. The haemodynamic effects of repeated intravenous administrations of reference compounds were analyzed in order to validate the guinea pig model for safety pharmacology studies under GLP conditions. Male guinea pigs (n=54, weighing 565-762 g) were anaesthetized using 1.5 g/kg, i.p., urethane. Systolic arterial blood pressure (SAP), diastolic arterial blood pressure (DAP), heart rate (HR), left ventricular pressure (LVP), cardiac contractility (dp/dt(max)), and ECG (RR, QT, and QTc intervals) were recorded continuously. Animals received vehicle i.v. followed by cumulative doses of reference compounds. Vehicle did not produce any relevant changes, either in cardiovascular or ECG parameters. Isoproterenol caused a rapid and significant increase in HR, LVP, and dp/dt(max), in contrast to a dose-dependent decrease in SAP and DAP. Epinephrine led to a potent increase in all cardiovascular parameters. Nifedipine produced a slight decrease in HR and LVP, and a potent decrease in blood pressure and dp/dt(max). Verapamil caused a dose-dependent decrease in all cardiovascular parameters. Ouabain...Continue Reading


Dec 10, 1991·European Journal of Pharmacology·P Salinas, S Barrigón
Dec 15, 1990·JAMA : the Journal of the American Medical Association·B P MonahanL R Cantilena
Mar 1, 1989·The Journal of Pharmacy and Pharmacology·T KogaK Sakai
Jan 1, 1989·Life Sciences·E WeinhouseD B Nudel
Apr 1, 1988·British Journal of Pharmacology·R M Tripathi, R Kaushal
Jan 1, 1983·Annals of the New York Academy of Sciences·L R Soma
Jan 1, 1995·Journal of Cardiovascular Pharmacology·S P PinneyR L Woosley
Feb 1, 1995·Journal of Autonomic Pharmacology·R E Howell, M P Kovalsky
Dec 1, 1994·Journal of Pharmacological and Toxicological Methods·E HayesM J Walker
Mar 1, 1994·Clinical and Experimental Hypertension : CHE·M J DePasqualeAnthony A Fossa
Apr 1, 1996·The Journal of Pharmacy and Pharmacology·M J HagertyK A Kane
Oct 26, 1999·Life Sciences·T MinematsuT Iga
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·M ToniniF Crema
Dec 22, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J Gras, J Llenas
Apr 4, 2000·Biological & Pharmaceutical Bulletin·T MinematsuT Iga
May 29, 2002·Fundamental & Clinical Pharmacology·Klaus Olejniczak, Gerd Bode
Jul 19, 2002·Cardiovascular Research·Chern-En ChiangPhilip Yu-An Ding
Nov 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·R L HamlinDavid M Hamlin
Feb 21, 2004·European Journal of Pharmacology·Anthony A FossaBernard Fermini
Mar 20, 2004·The Journal of Pharmacology and Experimental Therapeutics·Lin WuLuiz Belardinelli
Jun 3, 2004·Journal of Pharmacological and Toxicological Methods·Brian D GuthMichael Markert
Dec 21, 2005·Journal of Applied Animal Welfare Science : JAAWS·J L Albright


Nov 6, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Anusak KijtawornratR L Hamlin
Sep 21, 2013·Drug Discovery Today. Technologies·A S Y ChainO E Della Pasqua
Jun 21, 2012·Toxicology and Applied Pharmacology·Louise MarksJean-Pierre Valentin
Dec 20, 2011·Journal of Pharmacological and Toxicological Methods·Jens KågströmAnn-Christin Ericson
Nov 3, 2009·Hearing Research·H Christiaan StronksSjaak F L Klis
Dec 21, 2006·Journal of Molecular and Cellular Cardiology·Judith BrouilletteCéline Fiset
Jul 8, 2008·British Journal of Pharmacology·Michael K PugsleyM J Curtis
Jul 18, 2006·Journal of Pharmacological and Toxicological Methods·R L Hamlin
Jun 29, 2005·Journal of Pharmacological and Toxicological Methods·Michael K Pugsley
May 24, 2015·Journal of Pharmacological and Toxicological Methods·Pierre MorissetteChristopher P Regan
Jul 21, 2009·Journal of Pharmacological and Toxicological Methods·Liang GuoHeather Guthrie
Jun 4, 2011·Journal of Pharmacological and Toxicological Methods·William S Redfern, Jean-Pierre Valentin
May 8, 2013·Journal of Pharmacological and Toxicological Methods·Pierre MorissetteJoseph J Salata
Apr 28, 2016·Journal of Pharmacological and Toxicological Methods·Sabine RuppertMichael Hoffmann
Apr 18, 2013·PloS One·Jeonghyeon ParkYoung-Ran Yoon
Nov 26, 2016·British Journal of Pharmacology·Ling-Jun JieYan Wang
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Liang GuoKyle L Kolaja
Mar 31, 2010·Journal of Cardiovascular Pharmacology·Michal ZorniakTadeusz F Krzeminski
Jun 29, 2007·Drugs in R&D·Gilles Hanton

Related Concepts

Anesthesia Procedures
Cardiovascular Agents
Cardiovascular System
Dose-Response Relationship, Drug
Medicinal Plants Testing, Preclinical
Pharmaceutical Preparations
Electrocardiographic Recorders
Cavia porcellus

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.